PERIOLIMEL Trademark

Trademark Overview

On Thursday, November 17, 2022, a trademark application was filed for PERIOLIMEL with the United States Patent and Trademark Office. The USPTO has given the PERIOLIMEL trademark a serial number of 97682346. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, April 28, 2025. This trademark is owned by Baxter International Inc.. The PERIOLIMEL trademark is filed in the Pharmaceutical Products category with the following description:

PARENTERAL PHARMACEUTICALS, namely, INTRAVENOUS NUTRITIONAL SOLUTIONS SOLD IN MIXING CONTAINERS HAVING TWO OR MORE CHAMBERS

General Information

Serial Number97682346
Word MarkPERIOLIMEL
Filing DateThursday, November 17, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, April 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2023

Trademark Statements

Goods and ServicesPARENTERAL PHARMACEUTICALS, namely, INTRAVENOUS NUTRITIONAL SOLUTIONS SOLD IN MIXING CONTAINERS HAVING TWO OR MORE CHAMBERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, November 21, 2022NEW APPLICATION ENTERED
Thursday, December 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 30, 2023ASSIGNED TO EXAMINER
Wednesday, August 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 1, 2024SOU EXTENSION 1 FILED
Monday, April 1, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 1, 2024SOU EXTENSION 1 GRANTED
Friday, October 18, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2024SOU EXTENSION 2 FILED
Friday, October 18, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 16, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 16, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 28, 2025SOU EXTENSION 3 FILED
Monday, April 28, 2025SOU EXTENSION 3 GRANTED
Tuesday, April 29, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 16, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 16, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 16, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 16, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

periolimel containers mixing having more chambers sold solutions pharmaceuticals namely intravenous